Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65
Year: 2010
Type: article
Source: Current Gene Therapy
Institution: Children's Hospital of Philadelphia
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: recombinant adeno-associated virus vectors, Leber congenital amaurosis, gene therapy manufacturing, regulatory affairs, cyclic GMP, RPE65, electroretinogram, alpha-1 antitrypsin deficiency, Batten disease, Canavan disease, cystic fibrosis, hemophilia B, HIV infection, Parkinson's disease, muscular dystrophy, prostate cancer, melanoma, cation exchange chromatography, ampicillin
Open Access status: closed
OpenAlex ID: W2023237579
